drugset / Trial / NCT00236418

A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures

NCT00236418

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of topiramate as an add-on therapy in epilepsy patients with uncontrolled primary generalized tonic-clonic seizures, who are taking 1 or 2 standard antiepileptic drugs.

Timeline

Start
1994-12
Primary completion
Completion
1996-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 175 mg Oral
Subject Topiramate Small molecule 400 mg Oral

Indications